Lysophosphatidylcholine activates extracellular-signal-regulated protein kinase and potentiates vascular contractile responses in rat aorta

Journal of Pharmacological Sciences

Volumn 92, Issue 4, 2003, Pages 348-358

  Suenaga, Hiroshi ^a   Kamata, Katsuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Cytosolic Ca2+ level; Extracellular signal regulated protein kinase; Lysophosphatidylcholine; Mitogen activated protein kinase; Adrenoceptor agonist

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CALCIUM ION; GENISTEIN; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NICARDIPINE; POTASSIUM ION; U 0124; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; NONHUMAN; RAT; WESTERN BLOTTING;

EID: 0042695937     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.92.348     Document Type: Article

References (35)

1. Young SG, Parthasarathy S. Why are low-density lipoproteins atherogenic? West J Med. 1994;160:153-164.
2. Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 1984;54:711-718.
3. Jayakody L, Senaratne M, Thompson A, Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res. 1987;60:251-264.
4. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
5. Yla-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
6. Steinberg D, Witztum JL. Lipoproteins and atherogenesis: Current concepts. JAMA. 1990;264:3047-3052.
7. Kobayashi T, Matsumoto, T, Kamata K. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats. Br J Pharmacol. 2000;131:231-238.
8. Cox DA. Cohen ML. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: Clinical and pharmacological implications in atherosclerosis. Pharmacol Rev. 1996;48:3-19.
9. Galle J, Bassenge E, Busse R. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res. 1990;66:1287-1293.
10. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
11. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 1984;81:3883-3887.
12. Yokoyama M, Hirata K, Miyake R, Akita H, Ishikawa Y, Fukuzaki H. Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 1990;168:301-308.
13. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.
14. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Evidence for selective inhibition by lysophosphatidylcholine of acetylcholine-induced endothelium-dependent hyperpolarization and relaxation in rat mesenteric artery. Br J Pharmacol. 1995;116:1541-1453.
15. 2+ mobilization in the aortic endothelium in streptozotocin-induced diabetic and cholesterol-fed mice. Br J Pharmacol. 1998;123:1509-1516.
16. 2+ in rat aorta. Eur J Pharmacol. 1998;361:217-226.
17. 2+ level and contraction on exposure of rat aorta to lysophosphatidylcholine. Eur J Pharmacol. 1993;378:177-186.
18. Suenaga H, Kamata K. Lysophosphatidylcholine potentiates vascular contractile responses in rat aorta via activation of tyrosine kinase. Br J Pharmacol. 2002;135:789-799.
19. Tibbles LA, Woodgett JR. The stress-activated protein kinase pathways. Cell Mol Life Sci. 1999;55:1230-1254.
20. Denhardt DT. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling. Biochem J. 1996;318:729-747.
21. Watts SW. Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: Use of the mitogen-activated protein kinase kinase inhibitor PD098059. J Pharmacol Exp Ther. 1996;279:1541-1550.
22. Garcha RS, Sever PS, Hughes AD. Mechanism of action of angiotensin II in human isolated subcutaneous resistance arteries. Br J Pharmacol. 2001;134:188-196.
23. Ratz PH. Regulation of ERK phosphorylation in differentiated arterial muscle of rabbits. Am J Physiol Heart Circ Physiol. 2001;281:H114-H123.
24. Yamakawa T, Eguchi S, Yamakawa Y, et al. Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells. Hypertension. 1998;31:248-253.
25. Della Rocca GJ, Van Biesen T, Daaka Y, Luttrell DJ, Luttrell LM, Lefkowitz RJ. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem. 1997;272:19125-19132.
26. Favata MF, Horiuchi KY, Manos EJ, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 1998;273:18623-18632.
27. Takahashi E, Berk BC. MAP kinases and vascular smooth muscle function. Acta Physiol Scand. 1998;164:611-621.
28. Zheng XL, Renaux B, Hollenberg MD. Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: Blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3′-kinase. J Pharmacol Exp Ther. 1998;285:325-334.
29. 2 adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein. Br J Pharmacol. 2001;133:859-866.
30. Adam LP, Franklin MT, Raff GJ, Hathaway DR. Activation of mitogen-activated protein kinase in porcine carotid arteries. Circ Res. 1995;76:183-190.
31. Savineau JP, Marthan R. Modulation of the calcium sensitivity of the smooth muscle contractile apparatus: Molecular mechanisms, pharmacological and pathophysiological implications. Fundam Clin Pharmacol. 1997;11:289-299.
32. Touyz RM, He G, Deng LY, Schiffrin EL. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. Circulation. 1999:99:392-399.
33. 2-induced arterial muscle contraction. Am J Physiol Heart Circ Physiol. 2000:279:H1194-H1200.
34. Mulvaney JM, Zhang T, Fewtrell C, Roberson MS. Calcium influx through L-type channels is required for selective activation of extracellular signal-regulated kinase by gonadotropin-releasing hormone. J Biol Chem. 1999;274:29796-29804.
35. Portman OW, Alexander M. Lysophosphatidylcholine concentrations, metabolism in aortic intima plus inner media: Effect of nutritionally induced atherosclerosis. J Lipid Res. 1969;10:158-165.